RSM logo
International Journal of STD & AIDS

Home Current issue Browse archive Alerts About the journal Feedback
 
Int J STD AIDS 2009;20:360-361
doi:10.1258/ijsa.2008.008133
© 2009 Royal Society of Medicine Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirst, H
Right arrow Articles by Dinsmore, W W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Audit reports

Chlamydia Screening Programme, HMP Hydebank Wood Young Offender Centre, Belfast, Northern Ireland, UK

H Hirst MRPharmS MPSNI *  and W W Dinsmore MD FRCP {dagger}

* Senior Prison Pharmacist NIPS, HMP Hydebank, Wood, Hospital Road, Belfast BT8 8NA, UK; {dagger} Department of Genito-Urinary Medicine, Royal Victoria Hospital Belfast Trust, Grovesnor Road, Belfast BT12 6BA, UK

Correspondence to: Dr H Hirst Email: helen.hirst{at}boots.co.uk

In a young offender's centre, 204 male prisoners were offered chlamydia screening, from January 2007 to April 2007. The aim of this screening programme was to identify and treat asymptomatic prisoners with chlamydia infection. Offering the screening within a prison was an opportunity to test a hard-to-reach population that is at high risk of chlamydia infection. The programme established a high level of testing acceptability with a 98% screening uptake rate. Using nucleic acid amplification testing, 21 (10.5%) tested prisoners were positive for Chlamydia trachomatis. Patients were treated under Patient Group Direction (PGD). Further screening for sexually transmitted diseases was offered to chlamydia-positive patients by the genitourinary (GU) medicine specialist.

Key Words: chlamydia (Chlamydia trachomatis) • bacterial disease


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




MDU Exam Doctor